Lördag 21 December | 19:56:47 Europe / Stockholm
Svenska | English

Modulight

Kursutveckling under dagen för detta pressmeddelande (EUR).

Likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Tid*
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-05-06 - X-dag ordinarie utdelning MODU 0.00 EUR
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-10-20 - 15-10 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2023-05-02 - Årsstämma
2023-04-28 - 15-10 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2022-05-02 - Årsstämma

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består primärt av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.
Modulight to publish its interim report for January–March 2024 on April 26, 2024
2024-04-19 15:00:00

Modulight Corporation | Press Release | April 19, 2024 at 16:00:00 EEST

Modulight Corporation will publish its interim report for January–March 2024 on Friday, April 26, 2024, approximately at 1:00 p.m. EEST.
 
Modulight's CEO Seppo Orsila will present the result in an English-language webcast, which will be held on Monday April 29, 2024, at 2:00 p.m. EEST. The broadcast can be followed at https://modulight.zoom.us/webinar/register/WN_2ZGCvCXqQvCSXFssiRIMsw.

Questions are to be submitted in writing in the webcast portal. CFO Anca Guina will also be present to answer questions. Presentation materials will be available before the start of the event on the company’s website at https://modulight.com/reports-presentations/.

Contacts

CEO Seppo Orsila m. +358 40 830 4671
CFO Anca Guina m. +358 40 830 4674
IR Ulla Haapanen m. +358 40 830 4676
Email: ir@modulight.com

Modulight in brief

Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.

Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #killcancer #laserfamily

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden